BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 23, 2008
View Archived Issues
LY-450139 meets efficacy and safety endpoints in Alzheimer's disease phase II study
Read More
Abbott's ABT-869 shows activity against hepatocellular carcinoma in a phase II study
Read More
[188Re]-HDD-lipiodol studied for hepatocellular carcinoma in Mongolia
Read More
New data on bazedoxifene and bazedoxifene/CE in osteoporosis available
Read More
Regeneron and Columbia University sign agreement for VelocImmune mice
Read More
Pharmacopeia identifies new lead compound for advancement in alliance with GSK
Read More
Auxilium initiates dosing in phase IIb trial of Xiaflex in Peyronie's disease
Read More
Recent patent literature describes new anticancer agents
Read More
Omeros and The Parkinson's Institute sign collaboration to evaluate a molecular target in PD
Read More
Ovation acquires U.S. rights to Xenazine for chorea associated with HD
Read More
Merck Serono completes enrollment in REFLEX phase III trial of Rebif in MS
Read More
Memory and Roche expand R-3487/MEM-3454 development program
Read More
Sanofi pasteur sponsors MEL11 phase II clinical study of ALVAC vaccine in cancer
Read More
AMT and Amgen enter license agreement to develop gene therapy for PD
Read More
Merck & Co. discontinues license and research collaboration agreement with SurModics
Read More
Talecris signs exclusive license agreement with Crucell for PER.C6 technology
Read More
Interim results for a novel DNA plasmid BHT-3021 from a phase I/II type 1 diabetes study
Read More
Avigen completes multicenter AV-650 phase IIb spasticity trial in MS
Read More
EMEA recommends orphan drug designation for AX-200 in spinal cord injury
Read More
FDA issues complete response letter to Roche for Actemra BLA
Read More
New agents for treating neurological disorders disclosed in recent patents
Read More
Recent patents report novel treatments for obesity
Read More
Sanofi-aventis Europe intends to raise offer to acquire Zentiva
Read More
Enobia receives FDA orphan drug designation for ENB-0040 in hypophosphatasia
Read More
EMEA grants orphan drug designation to ATIR for graft-versus-host disease
Read More
KeyNeurotek receives EMEA orphan drug designation for KN-38-7271
Read More
Anisodamine eliminates NSAID-induced ulcers in vivo
Read More
